PR Newswire (Wed, 7:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,181 people get SVNT articles and Market Currents by email alert.
Get email alerts on SVNT »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
PR Newswire (Mar 19, 2013)
-
Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.PR Newswire (Feb 19, 2013)
-
-
-
PR Newswire (Jan 8, 2013)
-
PR Newswire (Jan 4, 2013)
-
PR Newswire (Dec 5, 2012)
-
-
-
PR Newswire (Nov 8, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Look Beyond the Botched Buyout Process for Savient's ValueStone Fox Capital • Wed, Oct 27, 2010
-
-
-
-
-
What Moves Biotech Stocks? Ed Arce Has AnswersLife Sciences Report • Thu, Oct 18, 2012 -
-
-
-
-
-
-
-
-
-
-
-
-
-
4 Highly Liquid Biotech Stocks With Bullish Short TrendsKapitall • Thu, May 10, 2012
-
-
AstraZeneca Sprinting To Fix ItselfStephen Simpson • Thu, Apr 26, 2012
-
Savient Pharmaceuticals, Inc Q2 2010 Earnings Call TranscriptWed, Aug 4, 2010
-
Savient Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptSat, May 8, 2010
-
Savient Pharmaceuticals, Inc. Q1 2009 Earnings Call TranscriptFri, May 8, 2009
-
Savient Pharmaceuticals, Inc, Q4 Year Earnings Call TranscriptThu, Feb 26, 2009
-
Savient Pharmaceuticals, Inc. Q4 2007 Earning Call TranscriptWed, Mar 12, 2008
-
Savient Pharmaceuticals Q3 2007 Earnings Call TranscriptWed, Oct 31, 2007
-
PR Newswire (Wed, 7:00AM)
-
PR Newswire (Mar 19, 2013)
-
Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.PR Newswire (Feb 19, 2013)
-
PR Newswire (Jan 8, 2013)
-
PR Newswire (Jan 4, 2013)
-
PR Newswire (Dec 5, 2012)
-
PR Newswire (Nov 8, 2012)
-
PR Newswire (Oct 19, 2012)
-
PR Newswire (Sep 26, 2012)
-
at MarketWatch.com (Sep 25, 2012)
-
PR Newswire (Sep 24, 2012)
-
at CNBC.com (Sep 19, 2012)
-
PR Newswire (Sep 5, 2012)
-
PR Newswire (Aug 27, 2012)
SVNT vs. ETF Alternatives
Company Description
We are a specialty biopharmaceutical company focused on developing KRYSTEXXA™ (pegloticase), or KRYSTEXXA, for the treatment of chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 15, 7:04 AM Savient Pharmaceuticals (SVNT): Q1 EPS of -$0.34 misses by $0.03. Revenue of $4.7M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, May 15, 12:05 AM Notable earnings before Wednesday’s open: AG, AH, CSC, DE, EJ, GLOG, M, OXF, PF, SVNT, WMC Comment! [Earnings]
- Tuesday, May 14, 5:30 PM Notable earnings before Wednesday’s open: AG, AH, CSC, DE, EJ, GLOG, M, OXF, PF, SVNT, WMC Comment! [Earnings]
- Tuesday, March 19, 12:00 PM Savient Pharmaceuticals (SVNT -9%) takes a hit after its Q4 beat expectations on a per share basis, but came up far short on revenue as net sales of Krystexxa posted a marginal 3% increase over Q3. Bottom line margins were also impacted by a cost of goods charge to Krystexxa inventory that the company doesn't believe will be sold prior to expiration. 1 Comment [Healthcare, On the Move]
- Tuesday, March 19, 7:04 AM Savient Pharma (SVNT): Q4 EPS of -$0.39 beats by $0.06. Revenue of $4.9M (+33% Y/Y) misses by $1.28M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, March 19, 12:05 AM Notable earnings before Tuesday’s open: DSW, FDS, RNF, SVNT, WAC Comment! [Earnings]
- Monday, March 18, 5:30 PM Notable earnings before Tuesday’s open: DSW, FDS, RNF, SVNT, WAC Comment! [Earnings]
-
Monday, November 12, 2012, 9:10 AM
Premarket gainers: TIE +43%. JEF +24%. MYRX +17%. CXS +15%. GILD +12%. CELG +10%. SVNT +7%. SQNM +7%. LUK +7%. RIMM +6%. NKTR +6%. STV +5%. DNDN +5%. CEL +5%. PCP +5%.
Losers: CLVS -41%. STSI -20%. NBG -11%. Comment! [On the Move] - Thursday, November 8, 2012, 12:45 PM Midday top 10 gainers: DUSA +38%. PRMW +23%. ARX +22%. RST +22%. ES +19%. FALC +18%. UPIP +18%. SAPE +17%. PRSC +17%. MWW +17%. Midday top 10 Losers: CPRX -62%. BCRX -39%. COBR -24%. PRSS -21%. CALI -21%. UPG -20%. SVNT -19%. TRU -19%. MITK -19%. PANL -18%. Comment!
-
Thursday, November 8, 2012, 9:10 AM
Premarket gainers: DUSA +38%. MTSL +28%. USAT +15%. WLL +11%. ITMN +11%. SD +9%. QCOM +9%. THQI +8%. EZCH +7%. ALU +6%. MWW +7%. TTM +6%. DF +5%.
Losers: CPRX -56%. BCRX -34%. PANL -25%. SVNT -19%. SGEN -11%. MNST -10%. CNQR -9%. TNK -9%. NBG -8%. PSTI -8%. MAKO -7%. WINI -6%. AUI -5%. Comment! [On the Move] - Thursday, November 8, 2012, 7:18 AM Savient Pharmaceuticals (SVNT): Q3 EPS of -$0.56 misses by $0.08. Revenue of $4.5M misses by $1.3M. (PR) Comment! [Earnings, Healthcare]
- Thursday, November 8, 2012, 12:05 AM Notable earnings before Thursday’s open: AAP, AINV, AMRC, APU, BCRX, CNQ, DF, DUK, EBIX, ES, EZCH, FE, FSYS, GTXI, HK, KIOR, KSS, MFC, MWW, NOG, PGNX, PMT, POZN, PPL, SMBL, SNSS, SVNT, THI, TNK, VMC, WEN, WIN Comment! [Earnings]
- Wednesday, November 7, 2012, 5:30 PM Notable earnings before Thursday’s open: AAP, AINV, AMRC, APU, BCRX, CNQ, DF, DUK, EBIX, ES, EZCH, FE, FSYS, GTXI, HK, KIOR, KSS, MFC, MWW, NOG, PGNX, PMT, POZN, PPL, SMBL, SNSS, SVNT, THI, TNK, VMC, WEN, WIN 1 Comment [Earnings]
-
Friday, October 19, 2012, 9:10 AM
Premarket gainers: SVNT +12%. RVBD +11%. CALL +7%. SNDK +7%.
Losers: CBLI -20%. ATHN -11%. CMG -11%. MRVL -9%. PH -9%. ETFC -6%. Comment! [On the Move] - Wednesday, August 8, 2012, 7:43 AM Savient Pharmaceuticals (SVNT): Q2 EPS of -$0.23 beats by $0.22. Revenue of $4.6M (+133% Y/Y) misses by $0.6M. (PR) Comment! [Earnings, Healthcare]
- Wednesday, August 8, 2012, 12:05 AM Notable earnings before Wednesday’s open: AINV, ANR, AONE, ATRS, BCE, CLH, CSC, CWH, DF, DISH, ES, EZCH, FSYS, HFC, M, NRG, PPL, RL, SODA, SVNT, SWC Comment! [Earnings]
-
- View all 0 replies
-
- View all 0 replies
-
Cosmospepper
SVNT will be bankrupt, sold or de-listed before Karl Rove is released from the nut house! - View all 0 replies
-
Stone Fox Capital
thx $SVNT management for not even excluding the severance costs in the report. Trying to tank the stock on purpose? - View all 0 replies
-
aeromitch37
Any thoughts on SVNT? I bought at $2.27 and have been murdered since? Should I continue to hold? or sell and take the loss? - View all 0 replies
-
Stone Fox Capital
crazy stuff from $OCZ cutting 28% of non-production workforce. When $SVNT did a similar reduction the stock roared soon after. - View all 3 replies
-
FortSumter: Yeah, imagine the morale there going forward. I've been in that environment and productivity goes to zero as everyone "looks forward". -
Stone Fox Capital: The mega-caps don't b/c the cuts lead to more revenue problems. Small caps though can re-org and focus their way to a turnaround.
-
- View all 0 replies
-
- View all 0 replies
-
Red Acre Investments
$SVNT get EU approval for pegloticase - expect volatile trading as this is last day before op.ex. too - View all 0 replies
-
- View all 2 replies
-
Susan Kilburg: SVNT classic setup. Two weeks of consolidation; volume drying up and a bear raid this morning created a perfect buying opportunity.
-
LATEST REPLIES
-
Stone Fox Capital
crazy stuff from $OCZ cutting 28% of non-production workforce. When $SVNT did a similar reduction the stock roared soon after. - View all 3 replies
-
FortSumter: Yeah, imagine the morale there going forward. I've been in that environment and productivity goes to zero as everyone "looks forward".
-
Stone Fox Capital: The mega-caps don't b/c the cuts lead to more revenue problems. Small caps though can re-org and focus their way to a turnaround.
-
- View all 2 replies
-
Susan Kilburg: SVNT classic setup. Two weeks of consolidation; volume drying up and a bear raid this morning created a perfect buying opportunity.
-
-
- View all 1 replies
-
Susan Kilburg: profit taking and short interest declining as they cover. Absent news, it's the same old same old...
-
- View all 1 replies
-
-
Stone Fox Capital
$SVNT keeps powering ahead to $2.08. Though the 200ema would be a ceiling but it just powered thru... nice - View all 2 replies
-
WildSoccer: Not sure if you're kidding. So if you bought SVNT anytime in the last 15 years except for the last month you're losing money. Nice volume.
-
WildSoccer: Should clarify.SVNT broke through LT downtrend on excell. volume. Next resist. prob.50% higher or so.Nice % upside.Still don't like company.
-
- View all 1 replies
-